Disruption of low- and high-density human plasma lipoproteins and phospholipid dispersions by 1-anilinonaphthalene-8-sulfonate.
D000814:Aniline Compounds / Q000302:isolation & purification; D001665:Binding Sites; D001798:Blood Proteins / Q000032:analysis / Q000302:isolation & purification; D002499:Centrifugation, Density Gradient; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol / Q000032:analysis; D002845:Chromatography; D002855:Chromatography, Thin Layer; D003956:Dialysis; D004952:Esters / Q000032:analysis; D006801:Humans; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000032:analysis / Q000097:blood* / Q000302:isolation & purification; D046911:Macromolecular Substances; D008433:Mathematics; D008970:Molecular Weight; D009281:Naphthalenes / Q000302:isolation & purification*; D010713:Phosphatidylcholines; D010743:Phospholipids / Q000032:analysis / Q000097:blood*; D011485:Protein Binding; D013053:Spectrophotometry; D013451:Sulfonic Acids / Q000302:isolation & purification*; D014280:Triglycerides / Q000032:analysis; D014461:Ultracentrifugation
D000814:Aniline Compounds; D001798:Blood Proteins; D004952:Esters; D008055:Lipids; D008074:Lipoproteins; D046911:Macromolecular Substances; D009281:Naphthalenes; D010713:Phosphatidylcholines; D010743:Phospholipids; D013451:Sulfonic Acids; D014280:Triglycerides; D002784:Cholesterol